Samuel Herron is a science advisor in the firm’s Litigation department.
Dr. Herron received his Doctorate in Philosophy from the University of Pittsburgh School of Medicine, wherein his research focused on mRNA processing. In his dissertation work, Dr. Herron utilized molecular biology and genetic techniques to characterize the regulation of mRNA isoform expression by the mTOR pathway, an essential signaling pathway in cellular growth. Dr. Herron has additional research experience with gene editing technology, next generation sequencing, and viral vector delivery systems.
Areas of Practice
University of Pittsburgh
Virginia Polytechnic Institute and State University
Dr. Herron has published scientific articles in peer-reviewed journals and textbooks, including Cell Reports and Methods in Enzymology.